nitrazepam has been researched along with Obesity in 1 studies
Nitrazepam: A benzodiazepine derivative used as an anticonvulsant and hypnotic.
nitrazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome).
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abernethy, DR | 1 |
| Greenblatt, DJ | 1 |
| Locniskar, A | 1 |
| Ochs, HR | 1 |
| Harmatz, JS | 1 |
| Shader, RI | 1 |
1 other study available for nitrazepam and Obesity
| Article | Year |
|---|---|
Obesity effects on nitrazepam disposition.
Topics: Adult; Blood Proteins; Female; Half-Life; Humans; Kinetics; Male; Nitrazepam; Obesity; Protein Bindi | 1986 |